Rohan Singh 
Dealstreet

Fox Mandal & Associates assists Samarsh Capital on investment in SAI Parenterals

Samarsh Capital led SAI Parenterals' ₹50 crore fundraise.

Bar & Bench

Fox Mandal & Associates LLP has advised Samarsh Capital on leading the ₹50 crore fundraise of Sai Parenterals Limited.

The transaction team consisted of Rohan Singh (Partner) and Siddhi Kasekar (Associate).

Sai Parenterals

SAI Parenteralis an Indian pharmaceutical company with a proven track record in the formulations segment which operates across the pharmaceutical value chain, including research & development (R&D), manufacturing, regulatory compliance, marketing, and exports.

The Company will utilize the funds for global expansion, enhancement of manufacturing capabilities and diversification of product offering.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

What the India AI Impact Summit means for Indian legal practice

Delhi HC seeks CBI's stance on plea to re-investigate death of former Railway Minister LN Mishra in 1975 blasts

WBNUJS wins CNLU-DPIIT-IPR National Moot

CBI moves Delhi High Court against discharge of Arvind Kejriwal, Manish Sisodia, others in excise policy case

Grossest abuse of office: Supreme Court on judge who filed case against own brother

SCROLL FOR NEXT